Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol. 2007;31:19–25.
Pinninti SG, Kimberlin DW. Neonatal herpes simplex virus infections. Semin Perinatol. 2018;42:168–75.
Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med. 2009;361:1376–85.
Article CAS PubMed PubMed Central Google Scholar
Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Newman LM, et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health. 2017;5:e300–9.
Article PubMed PubMed Central Google Scholar
Kimberlin DW, Lin C-Y, Jacobs RF, Powell DA, Corey L, Gruber WC, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108:230–8.
Article CAS PubMed Google Scholar
Donda K, Sharma M, Amponsah JK, Bhatt P, Okaikoi M, Chaudhari R, et al. Trends in the incidence, mortality, and cost of neonatal herpes simplex virus hospitalizations in the United States from 2003 to 2014. J Perinatol. 2019;39:697–707.
Mahnert N, Roberts SW, Laibl VR, Sheffield JS, Wendel GD Jr. The incidence of neonatal herpes infection. Am J Obstet Gynecol. 2007;196:e55–6.
Flagg EW, Weinstock H. Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatrics. 2011;127:e1–8.
Fernandes N, Sthapit B, Mhanna M, Abughali N. Evaluation of suspected neonatal herpes simplex virus infection in preterm versus term newborns in the neonatal intensive care unit. J Neonatal Perinat Med. 2020;13:387–94.
Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991;324:450–4.
Article CAS PubMed Google Scholar
Cruz AT, Freedman SB, Kulik DM, Okada PJ, Fleming AH, Mistry RD, et al. Herpes simplex virus infection in infants undergoing meningitis evaluation. Pediatrics. 2018;141:e20171688.
Spitzer AR, Ellsbury DL, Handler D, Clark RH. The pediatrix babysteps® data warehouse and the pediatrix qualitysteps improvement project system—tools for “meaningful use” in continuous quality improvement. Clin Perinatol. 2010;37:49–70.
Shah SS, Aronson PL, Mohamad Z, Lorch SA. Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics. 2011;128:1153–60.
Article PubMed PubMed Central Google Scholar
Kropp RY, Wong T, Cormier L, Ringrose A, Burton S, Embree JE, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics. 2006;117:1955–62.
Mark KE, Kim HN, Wald A, Gardella C, Reed SD. Targeted prenatal herpes simplex virus testing: can we identify women at risk of transmission to the neonate? Am J Obstet Gynecol. 2006;194:408–14.
Jones CA, Walker KS, Badawi N. Antiviral agents for treatment of herpes simplex virus infection in neonates. Cochrane Database Syst Rev. 2009;2009:Cd004206.
PubMed PubMed Central Google Scholar
Whitley RJ, Corey L, Arvin A, Lakeman FD, Sumaya CV, Wright PF, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis. 1988;158:109–16.
Article CAS PubMed Google Scholar
Ericson JE, Gostelow M, Autmizguine J, Hornik CP, Clark RH, Benjamin DK Jr., et al. Safety of high-dose acyclovir in infants with suspected and confirmed neonatal herpes simplex virus infections. Pediatr Infect Dis J. 2017;36:369–73.
Article PubMed PubMed Central Google Scholar
Ericson JE, Benjamin DK, Boakye-Agyeman F, Balevic SJ, Cotten CM, Adler-Shohet F, et al. Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease. Early Hum Dev. 2022;170:105616.
Article CAS PubMed PubMed Central Google Scholar
Cruz AT, Nigrovic LE, Xie J, Mahajan P, Thomson JE, Okada PJ, et al. Predictors of invasive herpes simplex virus infection in young infants. Pediatrics. 2021;148:e2021050052.
Caviness AC, Demmler GJ, Selwyn BJ. Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study. Pediatr Infect Dis J. 2008;27:425–30.
Cerdeña JP, Plaisime MV, Borrell LN. Race as a risk marker, not a risk factor: revising race-based algorithms to protect racially oppressed patients. J Gen Intern Med. 2024;39:2565–70.
Collins A, Weitkamp JH, Wynn JL. Why are preterm newborns at increased risk of infection? Arch Dis Child Fetal Neonatal Ed. 2018;103:F391–4.
van den Berg JP, Westerbeek EA, van der Klis FR, Berbers GA, van Elburg RM. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev. 2011;87:67–72.
Brady MT. Health care–associated infections in the neonatal intensive care unit. Am J Infect Control. 2005;33:268–75.
Article PubMed PubMed Central Google Scholar
Visscher MO, Adam R, Brink S, Odio M. Newborn infant skin: physiology, development, and care. Clin Dermatol. 2015;33:271–80.
Kotzbauer D, Frank G, Dong W, Shore S. Clinical and laboratory characteristics of disseminated herpes simplex virus infection in neonates. Hosp Pediatr. 2014;4:167–71.
Knezevic A, Martic J, Stanojevic M, Jankovic S, Nedeljkovic J, Nikolic L, et al. Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2. Emerg Infect Dis. 2007;13:302–4.
Article CAS PubMed PubMed Central Google Scholar
Melvin AJ, Mohan KM, Schiffer JT, Drolette LM, Magaret A, Corey L, et al. Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection. J Pediatr. 2015;166:827–33.
Comments (0)